Literature DB >> 1301942

A defective splice site at the phenylalanine hydroxylase gene in phenylketonuria and benign hyperphenylalaninemia among Palestinian Arabs.

S Kleiman1, J Bernstein, G Schwartz, R C Eisensmith, S L Woo, Y Shiloh.   

Abstract

Phenylketonuria (PKU) and benign hyperphenylalaninemia (HPA) result from different combinations of mutations at the locus for phenylalanine hydroxylase (PAH). While some of these mutations show widespread ethnic distribution, others are unique to specific communities. We report here the first point mutation common among Palestinian Arabs. The mutation (IVS2nt1) involves a dinucleotide substitution (Gg-->Aa) at the donor splice site of intron 2 of the PAH gene and abolishes a recognition site of the restriction enzyme MnlI. IVS2nt1 is associated with two PAH polymorphic haplotypes, 7 and 42. Homozygotes for this mutation are affected with severe, classical PKU. Compound heterozygotes carrying the IVS2nt1 allele and one of several other yet unknown mutations show different degrees of benign HPA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1301942     DOI: 10.1002/humu.1380010413

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  2 in total

1.  Genotype-phenotype correlations analysis of mutations in the phenylalanine hydroxylase (PAH) gene.

Authors:  Dani Bercovich; Arava Elimelech; Joel Zlotogora; Sigal Korem; Tal Yardeni; Nurit Gal; Nurit Goldstein; Bela Vilensky; Roni Segev; Smadar Avraham; Ron Loewenthal; Gerard Schwartz; Yair Anikster
Journal:  J Hum Genet       Date:  2008-02-26       Impact factor: 3.172

2.  Phenylketonuria in a low incidence population: molecular characterisation of mutations in Finland.

Authors:  P Guldberg; K F Henriksen; I Sipilä; F Güttler; A de la Chapelle
Journal:  J Med Genet       Date:  1995-12       Impact factor: 6.318

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.